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Abstract
Here we integrated multiphoton laser scanning microscopy and the registration of second harmonic
generation images of collagen fibers to overcome difficulties in tracking stromal cell-matrix
interactions for several days in live mice. We show that the matrix-modifying hormone relaxin
increased tumor-associated fibroblast (TAF) interaction with collagen fibers by stimulating β1-
integrin activity, which is necessary for fiber remodeling by matrix metalloproteinases.
Our current understanding of extracellular matrix remodeling derives from in vitro
experiments1,2, which are difficult to interpret and relate to in vivo physiology. Multiphoton
laser scanning microscopy and second harmonic generation (SHG) of fibrillar collagen allow
visualization of the matrix of normal and tumor tissues in vivo3. Using these technologies, it
is possible to study the real-time movement of cells through the collagen network on time scales
of minutes to hours4,5. However, the slow rate of extracellular matrix remodeling makes it
difficult to monitor matrix reorganization by stromal cells.
To track stromal cell collagen fiber interactions in vivo, we grew tumors (human sarcoma
HSTS26T) in transparent dorsal skinfold chambers of immunodeficient mice expressing GFP
under the control of the Vegfa promoter (VEGF-GFP mice). The transparent tumor chamber
facilitated the tracking of the same cells and fibers for several days (Supplementary Methods
online). Also, previous data in VEGF-GFP mice6 and our immunostaining results suggest that
peritumor GFP-positive cells are tumor-associated fibroblasts (TAFs) (Supplementary Fig. 1
online).
To induce collagen remodeling in a reliable fashion, we treated tumors with the small hormone
relaxin, which causes matrix remodeling and increases tumor invasion and progression7. In
vitro, relaxin enhanced the invasion of fibroblasts through increased collagen I degradation but
did not affect the HSTS26T tumor cells (Supplementary Fig. 2 online). These data suggest that
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HSTS26T cells implanted in VEGF-GFP transgenic mice could provide a model for studying
stromal-specific extracellular matrix remodeling. Because the SHG signal attenuates with
tissue depth, we were able to analyze collagen remodeling within 100 μm from the tumor
surface (Supplementary Methods).
Temporal changes in tumors and the inability to place mice under the microscope in the same
orientation between imaging sessions necessitated the development of a registration method
to align image sequences. The SHG signal arising from fibrillar collagen provided a convenient
registration landmark because of the relative stability and the wide distribution of collagen
fibers in comparison with other potential landmarks, such as blood vessels or exogenous
fluorescent beads. Blood vessels within tumors are porous to injected tracer particles, can have
time-dependent perfusion fluctuations and are more sparsely distributed than the extracellular
matrix, which forms a distinct network distributed throughout the tumor. Likewise, fluorescent
beads pose the problem of potentially being unevenly distributed in the region of interest or
being unstable because of photobleaching or cellular phagocytosis. We used an intensity-based
registration approach (Turboreg)8 to align subsequent imaged volumes with those at the initial
time point (Supplementary Methods).
After image registration, we assessed fibrillar collagen changes. For all images and time points
we measured mismatch in SHG signal, calculated by subtracting the maximum intensity
projection at a registered time point from its corresponding image at day 1 (Supplementary
Fig. 3 online). Mean SHG mismatch remained constant between day 1 and days 2, 3, 4 and 5
(Supplementary Fig. 4a online). The observed variation between time points was related to
changes in specimen alignment (imperfect physical registration) and accumulation of
biological changes (tissue growth and collagen reorganization). Mean mismatch values
remained constant between control phosphate-buffered saline–treated and relaxin-treated
tumors, even though it is well established that relaxin modifies fibrillar collagen structures3
(Supplementary Fig. 4b). The inability to detect relaxin-induced changes may indicate that
small modifications in fiber morphology may not affect SHG signal intensity, or that the
intrinsic noise of the SHG signal is greater than changes in fiber structure. Thus, SHG-based
registration offered two advantages: (i) it relied solely on an intrinsic signal that was widely
distributed and therefore did not require the insertion of external landmarks, and (ii) alignment
of registered volumes was stable for ~4 d and was not substantially influenced by tumor growth,
collagen fiber formation or relaxin treatment.
To track TAF migration and recruitment in HSTS26T tumors, we imaged 4–8 regions per
tumor every 24 h for 4 d. In some areas the number of TAFs increased, in others it decreased
and in some no change occurred; relaxin did not affect stromal cell recruitment (data not
shown). We evaluated the effect of relaxin on TAF migration by tracking selected cells
(Supplementary Video 1 online). The fraction of migrating TAFs was significantly lower (P
< 0.05) in relaxin-treated (37%, n = 68) tumors compared to control (57%, n = 89) tumors. We
defined a migrating cell as one with displacement of more than 10 μm from day 1 to day 4
(Supplementary Methods). Although relaxin reduced the fraction of migrating cells, it
significantly increased (P < 0.01) the speed of motile cells, from 11 ± 1.5 μm d−1 (range, 1–
41 μm d−1) in control to 21 ± 2 μm d−1 (range, 2–44 μm d−1) in relaxin-treated tumors. Notably,
the in vivo migration speed of TAFs is approximately one order of magnitude slower than
fibroblast movement in collagen gels (5–100 μm h−1)9,10.
A detailed analysis of single fibers indicated that TAFs could drag or push fibers during their
migration; after the cells detached, fibers either returned to their initial (‘resting’) position or
remained at their new conformation (Supplementary Video 2 online). In control tumors, the
collagen network was stable, whereas relaxin induced dramatic and permanent changes in fiber
morphology. The direct juxtaposition of TAFs with single fibers was often associated with
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fiber buckling or loss of fiber continuity (gap formation). In some cases, TAFs remained close
to a fiber for several days before we observed fiber buckling (Fig. 1 and Supplementary Video
3 online). Gap formation occurred in areas of cell-fiber interactions where fiber thinning could
initially be observed, followed by loss of fibrillar material 1–2 d later (Supplementary Video
4 online). Notably, continuous TAF-fiber juxtaposition was not required for gap formation, as
we observed cells temporarily interacting with fibers and moving on before the gap appeared.
Because bulk mismatch calculations were insensitive to detailed extracellular matrix changes
induced by relaxin, we analyzed individual fibers. First, we measured the end-to-end length of
randomly selected fibers (selected at day 1). Fiber length between day 1 and days 2, 3 and 4
significantly decreased (paired t-test P < 0.05) in the relaxin group but not in control tumors
(Fig. 2a). Next we assessed fiber buckling and loss of fiber continuity (gap formation; see
Supplementary Methods for how we interpreted the data to indicate buckling versus gap
formation). In relaxin-treated mice, we observed fiber buckling and gap formation in 53% and
15% of analyzed fibers, respectively. Notably, 15% of fibers in control tumors developed
buckles similar to those in relaxin-treated tumors, but fiber length was not affected. Moreover,
in some cases, collagen fibers exhibited higher-order reorganizations, with fibers winding
through the tissue in parallel groups, with evidence that relaxin caused buckling and
condensation remodeling at this larger scale as well (Supplementary Video 5 online).
Because collagen fiber remodeling was associated with close juxtapositions between TAFs
and fibers, we determined whether relaxin enhanced TAF-fiber overlap. We measured TAF-
fiber overlap as the area of interaction between TAFs and fibers, in pixels, normalized to the
length of the fiber, in micrometers. As a function of time, the overlap between cells and fibers
increased significantly in relaxin but not in control tumors (Fig. 2b; paired t-test P < 0.05). We
analyzed TAF movement and TAF-fiber overlap in volumes (regions of interest) with constant
and changed fiber lengths (Supplementary Methods). Of all TAFs tracked in the relaxin-treated
group, 65% of cells in regions with changing fiber lengths and 60% of cells in regions with
constant fiber lengths overlapped at least once with fibers, but the mean time of overlap per
cell was significantly longer (P < 0.05) in ‘changing’ (3 d ± 0.03 d) than in ‘constant’ (2.2 d ±
0.27 d) regions. In ‘changing’ regions, only 6% of TAFs overlapping with fibers were mobile
(>10 μm d−1) (Supplementary Table 1 online); in contrast, in ‘constant’ regions, 55% of TAFs
overlapping with fibers were mobile. In ‘changing’ regions of control tumors, 29% of TAFs
interacting with fibers were mobile. Taken together, these results suggest that relaxin stimulates
collagen fiber remodeling by increasing the number of less-motile cells that interact with fibers.
Flow cytometry analysis of GFP-positive cells revealed a potential adhesion pathway involved
in cell-fiber interactions: relaxin significantly increased the expression of β1 integrin (t-test;
P < 0.05) in GFP-positive cells (Fig. 3 and Supplementary Methods). β1 integrin enhances
matrix metalloproteinase-14 expression and activity in fibroblasts plated on collagen I
gels11. It is also thought that relaxin affects fibrillar collagen remodeling by stimulating the
expression and activity of matrix metalloproteinases such as MMP-1, -2 and -14 (refs. 7,12).
To determine the relationship between TAFs, β1 integrin, matrix metalloproteinases and
collagen remodeling, we treated tumors with relaxin combined with either a mouse β1 integrin–
blocking antibody or the pan–matrix metalloproteinase inhibitor GM6001. Both β1 integrin
and pan–matrix metalloproteinase blockade inhibited relaxin-induced fiber remodeling (Fig.
2a) but had differential effects on TAF-fiber interactions. β1 integrin blockade prevented the
relaxin-induced interaction between TAFs and fibers, whereas pan–matrix metalloproteinase
inhibition did not (Fig. 2b). Thus, in relaxin-treated tumors, both TAF adhesion to collagen
fibers, mediated by β1 integrin, and matrix metalloproteinase activity were essential for
collagen fiber remodeling.
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In conclusion, although prior studies have studied cell-matrix interactions in vitro or collagen
reorganization alone in vivo, to our knowledge our study is the first quantitative dissection of
stromal cell–extracellular matrix interactions in living tissue. The integration of image
registration with multiphoton laser scanning microscopy allowed us to track tissue-remodeling
events in which both TAFs and matrix are changing dynamically over multiple consecutive
days. Cell interactions with the extracellular matrix are central to fibrosis, wound healing, stem
cell recruitment and tissue engineering. Hence, our methodology could be applied to track
different cell types in healthy or diseased tissues in vivo.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Buckling of a collagen fiber in a relaxin-treated tumor. For each time point (days 1–9), the
SHG, GFP fluorescence, and the merged GFP fluorescence (green) and SHG (red) maximum
intensity projections of the acquired volumes are shown. Schematics of the images with the
collagen fiber (black) and two overlapping stromal cells (green) are shown at the bottom. Scale
bar, 10 μm.
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Quantitative analysis of collagen fiber length and area of colocalization between stromal cells
and fibers. (a,b) The end-to-end fiber length (a) and the area of overlap between stromal cells
and collagen fibers (b) was determined over 4 d in control groups as well as those treated with
relaxin, relaxin and β1 integrin antibody (R + β1) and relaxin and GM6001 (R + GM). Shown
are the averaged differences between day 1 and days 2 (D2-1), 3 (D3-1) and 4 (D4-1). A paired
t-test was performed for fiber length and area of overlap in all groups. Error bars, s.e.m.; *P <
0.05.
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Flow cytometry analysis of HSTS26T tumor–associated fibroblasts. Flow cytometry analysis
for CD-29 (β1 integrin), CD-49A (α1 integrin) and CD-49B (α2 integrin) was performed on
GFP-positive cells from HSTS26T tumors growing in VEGF-GFP mice. On average, GFP-
positive cells represented 1% of the 1 million events counted for each sample. The fraction of
GFP-positive cells expressing the respective integrin is shown for control and relaxin-treated
tumors. Error bars, s.e.m. (n = 3); *P < 0.05.
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